Thread: Epidemiology of PD in Germany
View Single Post
Old 10-03-2018, 06:03 PM
johnt johnt is offline
Senior Member
  
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
Default Epidemiology of PD in Germany
Heinzel et al. report [1]:

"Based on claims data of 3.7 million statutory insurance members in Germany in 2015 ... Prevalence of (co-)occurring diseases, mortality, and healthcare measures in PD cases and matched controls were compared. In 2015, 21,714 prevalent PD cases (standardized prevalence: 511.4/100,000 persons) and 3,541 incident PD cases (standardized incidence: 84.1/100,000 persons) were identified. Prevalence of several (co-)occurring diseases/complications, e.g., dementia (PD/controls: 39/13%), depression (45/22%), bladder dysfunction (46/22%), and diabetes (35/31%), as well as mortality (10.7/5.8%) differed between PD cases and controls."

Reference:

[1] "Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?"
Heinzel S., et al.
Front Neurol, June 2018
Frontiers | Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany? | Neurology

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote